NCDEX forays into equity markets with launch of two new indices
NCDEX has launched two equity indices, NDEX and FINNDEX, marking its strategic expansion beyond commodity derivatives into the equity segment.
Latest News
Amagi Media shares slip after company flags cybersecurity threat
Amagi Media has launched an investigation with external cybersecurity experts and legal counsel after a threat actor threatened to publish allegedly obtained operational data unless…
Largecap stocks may outperform as midcap rally loses steam, says JM Financial
JM Financial expects leadership in Indian equities to shift from midcap and smallcap stocks to largecaps as technical indicators improve. Rahul Sharma says the Nifty…
Q2 Results Underperformer: Stock falls 18% in three sessions after profit drops nearly 70%
Jindal Saw reported a 69.03% year-on-year decline in consolidated net profit. The stock has been on a selling spree since its results were announced, declining…
Here’s why SRF shares recovered 8% from the day’s low on Thursday
SRF said its two Chemours plants remain on track, with the first expected to be commissioned in the fourth quarter of FY27 and the second…
Stock Crash: eMudhra shares down 34% in three sessions; Management says ‘one-off incident on a bad day’
Shares of eMudhra declined 14.6% to hit an intraday low of ₹368.75 apiece on Thursday after falling 20% in the previous session. In the last…
Balkrishna Industries shares rise on proposed 50:50 Pirelli JV for passenger car tyres
The proposed joint venture will set up and operate a new manufacturing plant in India, subject to certain conditions. The two companies plan to execute…
Indian Hotels shares hit 52-week high after strong Q2 results and upgraded revenue outlook
Indian Hotels is targeting 50 openings in all of FY27. It is looking at opening over 30 hotels in the second half of the fiscal.
IMF’s Krishna Srinivasan says India should prioritise inflation as crude oil price risks rise
The IMF has warned that prolonged high crude oil prices remain a downside risk for Asia and India. Krishna Srinivasan said India’s central bank should…
Sagility’s Chirok Health Acquisition can boost its stock price by 31%, JPMorgan says
The acquisition should add 0.6% and 1% to Sagility’s FY27 and FY28 revenues, respectively, and JPMorgan estimates the transaction to be margin accretive as well.